Cargando…
ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis
To investigate the feasibility of using ICAM-1-targeted nano ultrasonic contrast to evaluate the degree of inflammatory injury at different stages in the abdominal aorta of rabbits with atherosclerosis (AS). Twenty-five experimental rabbits were assigned to five groups: the control group (A); the we...
Autores principales: | Li, Ping, Jin, Lin, Feng, Lan, Wang, Yingchun, Yang, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363608/ https://www.ncbi.nlm.nih.gov/pubmed/34389762 http://dx.doi.org/10.1038/s41598-021-96042-y |
Ejemplares similares
-
Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1
por: Xie, Fang, et al.
Publicado: (2016) -
ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator
por: Manthe, Rachel L., et al.
Publicado: (2017) -
Genetic variations in E-selectin and ICAM-1: Relation to atherosclerosis
por: Motawi, Tarek, et al.
Publicado: (2012) -
Testin on Atherosclerosis in Rabbits
por: Zhang, Yue, et al.
Publicado: (2015) -
Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent
por: Paulis, Leonie EM, et al.
Publicado: (2012)